Back
Science

Online Wellbeing Neuro Course Shows Long-Term Benefits for Mental Health and Disability in MS Patients

View source

Online Therapy Program Offers Hope for Mental Health in Multiple Sclerosis

Approximately one-third of individuals living with Multiple Sclerosis (MS) experience depression or anxiety, significantly impacting their daily functioning and quality of life. Access to crucial mental health care is often challenging for people with MS, hindered by factors such as cost, extensive waiting times, and physical accessibility limitations.

Cognitive Behavioral Therapy (CBT) is a recommended treatment for mental health challenges in MS. Online delivery of such treatments holds significant promise in addressing these pressing access barriers.

Introducing the Wellbeing Neuro Course

Dr. Milena Gandy and her team, with support from MS Australia, evaluated the effectiveness of an innovative program called the Wellbeing Neuro Course. This comprehensive 10-week online program integrates CBT principles with personalized support.

The Wellbeing Neuro Course combines CBT with weekly or bi-weekly support from a clinical psychologist via phone or a secure messaging system.

The CBT component is structured into six concise modules, each taking 10-15 minutes to complete. These modules focus on managing mental health and functional issues commonly associated with neurological disorders and include detailed case stories to enhance understanding and engagement.

The Study: Evaluating Effectiveness

The study, published in the Journal of Affective Disorders, compared two groups of MS patients: 72 individuals undertaking the Wellbeing Neuro Course and 61 individuals placed on a waiting list. Participants completed questionnaires at baseline, immediately post-treatment, and at follow-up points of three and 12 months.

Positive Outcomes and Lasting Impact

The results showed significant improvements in depression, anxiety, and disability for participants in the Wellbeing Neuro Course group compared to those on the waiting list.

Over half of the course participants experienced meaningful improvements in depression (56%) and anxiety (60%), a stark contrast to the 18% and 13% observed in the waiting list group, respectively.

Disability improvements were also noted, with 20% of course participants showing betterment compared to just 5% in the waiting list group. Crucially, these positive changes were sustained over the long term, evident at both the three and 12-month post-course follow-ups.

User satisfaction with the program was remarkably high, with 98% of participants reporting being satisfied or very satisfied. Furthermore, no negative side effects were reported throughout the study.

A Promising Path Forward

The study indicates that this online treatment is highly beneficial for MS patients experiencing mental health concerns, demonstrating long-term improvements and high user satisfaction. As an internet-delivered program, it offers significant potential for scalability and enhanced accessibility, addressing critical barriers to care.

While these findings are encouraging, further research is needed. Future studies with larger participant groups will help confirm these initial findings and assess the program's effectiveness across various MS types or symptom levels. Additionally, exploring the program's generalizability when administered by non-specialists in broader healthcare settings will be vital to further enhance treatment access for the wider MS community.